Growth Disorders - Ngenla Prior Authorization Policy
Customize your policy alerts
Sign up for Cigna Policy IP0577 alerts
Get alerted when Policy IP0577 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and prior authorization for Ngenla (somatrogon-ghla) for pediatric patients with growth failure due to inadequate growth hormone secretion, subject to the member’s benefit plan, applicable law, and the policy’s clinical and coding requirements.
A preferred specialty management requirement was added before Ngenla approval.
Pediatric growth hormone deficiency criteria were revised to add an alternative pathway using at least one subnormal stimulation test plus at least one growth hormone deficiency risk factor.
Congenital hypopituitarism criteria were expanded to include stimulation-test, other-pituitary-hormone-deficiency, and characteristic imaging pathways.
Preferred product requirements and preferred product tables were updated, and a Preferred Specialty Management Statement was added.
The requirement to rule out or correct other pituitary hormone deficiencies before testing was removed.
The brain radiation or tumor resection pathway was revised by removing the specified central nervous system pathology requirement.
Continuation and switching criteria were updated for patients established on growth hormone therapy.
Documentation requirements were added for continuation or switching therapy.
The conditions-not-covered section was revised, and several previously listed conditions and off-label uses were removed.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.